Marine Gross-Goupil

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Tyrosine Kinase

Radical Prostatectomy

Top Venues

Expert review of clinical pharmacology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Cancer innovation

This page only lists publications with an associated author ORCID identifier.

Publications

Mathieu Larroquette, Félix Lefort, Charlotte Domblides, Luc Héraudet, Grégoire Robert, Alain Ravaud, Marine Gross-Goupil
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma. Cancers 16 (9) (2024)
Robert J Motzer, Axel Bex, Paul Russo, Yoshihiko Tomita, Hernan Javier Cutuli, Carlos Rojas, Marine Gross-Goupil, Giovanni Schinzari, Bohuslav Melichar, Philippe Barthélémy, Abraham Ruiz Garcia, Jeffrey Sosman, Marc-Oliver Grimm, Jeffrey C Goh, Cristina Suarez, Christian K Kollmannsberger, Suresh G Nair, Brian M Shuch, Jian Huang, Burcin Simsek, Julia Spiridigliozzi, Chung-Wei Lee, Maximiliano van Kooten Losio, Viktor Gruenwald
Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mathieu Larroquette, Félix Lefort, Charlotte Domblides, Luc Héraudet, Grégoire Robert, Alain Ravaud, Marine Gross-Goupil
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma. Cancers 16 (9) (2024)
Roméo Baulain, Jérémy Jové, Dunia Sakr, Marine Gross-Goupil, Magali Rouyer, Marius Puel, Patrick Blin, Cécile Droz-Perroteau, Régis Lassalle, Nicolas H Thurin
Clustering of prostate cancer healthcare pathways in the French National Healthcare database. Cancer innovation 2 (1) (2023)
Nicolas H Thurin, Magali Rouyer, Jérémy Jové, Marine Gross-Goupil, Thibaud Haaser, Xavier Rébillard, Michel Soulié, Gérard de Pouvourville, Camille Capone, Marie-Laure Bazil, Fatiha Messaoudi, Stéphanie Lamarque, Emmanuelle Bignon, Cécile Droz-Perroteau, Nicholas Moore, Patrick Blin
Abiraterone acetate versus docetaxel for metastatic castration-resistant prostate cancer: a cohort study within the French nationwide claims database. Expert review of clinical pharmacology 15 (9) (2022)